Notice of NIAMS Participation in RFA-NS-20-008, "HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)"
Notice Number:
NOT-AR-21-024

Key Dates

Release Date:

July 16, 2021

Related Announcements

RFA-NS-20-008 - HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)

Issued by

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

This Notice informs potential applicants that the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is participating, effective immediately, in Funding Opportunity Announcement (FOA) RFA-NS-20-008 "HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)."

The following sections of RFA-NS-20-008 " have been modified to reflect NIAMS' participation in this FOA:

Currently Reads:

Part 1. Overview Information

Components of Participating Organizations

National Institute of Neurological Disorders and Stroke (NINDS)

National Eye Institute (NEI)

National Heart, Lung, and Blood Institute (NHLBI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute of General Medical Sciences (NIGMS)

National Institute of Mental Health (NIMH)

National Institute of Nursing Research (NINR)

National Institute on Minority Health and Health Disparities (NIMHD)

National Center for Complementary and Integrative Health (NCCIH)

National Cancer Institute (NCI)

Modified to Read (changes shown in bold italics):

Part 1. Overview Information

Components of Participating Organizations

National Institute of Neurological Disorders and Stroke (NINDS)

National Eye Institute (NEI)

National Heart, Lung, and Blood Institute (NHLBI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute of General Medical Sciences (NIGMS)

National Institute of Mental Health (NIMH)

National Institute of Nursing Research (NINR)

National Institute on Minority Health and Health Disparities (NIMHD)

National Center for Complementary and Integrative Health (NCCIH)

National Cancer Institute (NCI)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Currently Reads:

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.853, 93.213, 93.399, 93.393, 93.394, 93.395, 93.867, 93.838, 93.837, 93.839, 93.840, 93.233, 93.866, 93.273, 93.286, 93.865, 93.847, 93.859

Modified to Read (changes shown in bold italics):

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.853, 93.213, 93.399, 93.393, 93.394, 93.395, 93.867, 93.838, 93.837, 93.839, 93.840, 93.233, 93.866, 93.273, 93.286, 93.865, 93.847, 93.859, 93.846

The following additional sections have also been modified to include the following, demonstrating NIAMS' participation in this FOA (shown in bold italics):

Part 2. Full Text of Announcement, Section I. Funding Opportunity Description

Research Objectives

C. NIH Institute and Center Interests and Guidance

NIAMS

The mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases. For this FOA, NIAMS will only support applications proposing non-invasive technologies to manage pain in diseases of the NIAMS mission areas.

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)
Xibin Wang, PhD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-451-3884
Email:wangx1@mail.nih.gov

Financial/Grants Management Contact(s)
Ms. Victoria Matthews
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-3968
Email: victoria.matthews@nih.gov

All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Xibin Wang, PhD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-451-3884
Email: wangx1@mail.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices